Coupling and uncoupling of tumor immunity and autoimmunity

Citation
Wb. Bowne et al., Coupling and uncoupling of tumor immunity and autoimmunity, J EXP MED, 190(11), 1999, pp. 1717-1722
Citations number
22
Categorie Soggetti
Medical Research General Topics
Journal title
JOURNAL OF EXPERIMENTAL MEDICINE
ISSN journal
00221007 → ACNP
Volume
190
Issue
11
Year of publication
1999
Pages
1717 - 1722
Database
ISI
SICI code
0022-1007(199912)190:11<1717:CAUOTI>2.0.ZU;2-#
Abstract
Self-antigens, in the form of differentiation antigens, are commonly recogn ized by the immune system on melanoma and other cancers. We have shown prev iously that active immunization of mice against the melanocyte differentiat ion antigen, a tyrosinase-related protein (TRP) gp75(TRP-1) (the brown locu s protein) expressed by melanomas, could induce tumor immunity and autoimmu nity manifested as depigmentation. In this system, tumor immunity and autoi mmunity were mediated by autoantibodies. Here, we characterize immunity aga inst another tyrosinase family glycoprotein TRP-2 (the slaty locus protein) , using the same mouse model and method of immunization. As observed previo usly for gp75(TRP-1), immunity was induced by DNA immunization against a xe nogeneic form of TRP-2, but not against the syngeneic gene, and depended on CD4(+) cells. Immunization against TRP-2 induced autoantibodies and autore active cytotoxic T cells. In contrast to immunization against gp75(TRP-1), both tumor immunity and autoimmunity required CD8(+) T cells, but not antib odies. Only autoimmunity required perforin, whereas tumor immunity proceede d in the absence of perforin. Thus, immunity induced against two closely re lated autoantigens that are highly conserved through out vertebrate evoluti on involved qualitatively different mechanisms, i.e., antibody versus CD8T cell. However, both pathways led to tumor immunity and identical phenotyp ic man ifestations of autoimmunity.